1. Home
  2. NXPLW vs BDTX Comparison

NXPLW vs BDTX Comparison

Compare NXPLW & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPLW
  • BDTX
  • Stock Information
  • Founded
  • NXPLW N/A
  • BDTX 2014
  • Country
  • NXPLW United States
  • BDTX United States
  • Employees
  • NXPLW 166
  • BDTX N/A
  • Industry
  • NXPLW Telecommunications Equipment
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NXPLW Telecommunications
  • BDTX Health Care
  • Exchange
  • NXPLW Nasdaq
  • BDTX Nasdaq
  • Market Cap
  • NXPLW N/A
  • BDTX N/A
  • IPO Year
  • NXPLW N/A
  • BDTX 2020
  • Fundamental
  • Price
  • NXPLW $0.15
  • BDTX $1.57
  • Analyst Decision
  • NXPLW
  • BDTX Strong Buy
  • Analyst Count
  • NXPLW 0
  • BDTX 5
  • Target Price
  • NXPLW N/A
  • BDTX $15.60
  • AVG Volume (30 Days)
  • NXPLW 6.4K
  • BDTX 1.7M
  • Earning Date
  • NXPLW 03-31-2025
  • BDTX 05-08-2025
  • Dividend Yield
  • NXPLW N/A
  • BDTX N/A
  • EPS Growth
  • NXPLW N/A
  • BDTX N/A
  • EPS
  • NXPLW N/A
  • BDTX N/A
  • Revenue
  • NXPLW $66,482,000.00
  • BDTX N/A
  • Revenue This Year
  • NXPLW N/A
  • BDTX N/A
  • Revenue Next Year
  • NXPLW N/A
  • BDTX N/A
  • P/E Ratio
  • NXPLW N/A
  • BDTX N/A
  • Revenue Growth
  • NXPLW 179.89
  • BDTX N/A
  • 52 Week Low
  • NXPLW $0.25
  • BDTX $1.20
  • 52 Week High
  • NXPLW $0.26
  • BDTX $7.66
  • Technical
  • Relative Strength Index (RSI)
  • NXPLW N/A
  • BDTX 51.68
  • Support Level
  • NXPLW N/A
  • BDTX $1.31
  • Resistance Level
  • NXPLW N/A
  • BDTX $1.49
  • Average True Range (ATR)
  • NXPLW 0.00
  • BDTX 0.14
  • MACD
  • NXPLW 0.00
  • BDTX 0.04
  • Stochastic Oscillator
  • NXPLW 0.00
  • BDTX 88.79

About NXPLW NextPlat Corp

NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.

Share on Social Networks: